Mason Street Advisors, LLC Vanda Pharmaceuticals Inc. Transaction History

Mason Street Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$13.42 - $20.28 $273,700 - $413,610	-20,395 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $1,064 - $1,505	-109 Reduced 0.53%	20,395 $268,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $1,304 - $1,682	140 Added 0.69%	20,504 $198,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $17,252 - $21,467	1,786 Added 9.61%	20,364 $233,000
Q4 2019 Feb 19, 2020	BUY	$12.38 - $17.47 $6,053 - $8,542	489 Added 2.7%	18,578 $305,000
Q3 2019 Nov 05, 2019	BUY	$12.27 - $15.79 $5,030 - $6,473	410 Added 2.32%	18,089 $240,000
Q2 2019 Aug 12, 2019	BUY	$13.37 - $18.85 $10,321 - $14,552	772 Added 4.57%	17,679 $249,000
Q1 2019 May 07, 2019	BUY	$17.59 - $31.05 $10,888 - $19,219	619 Added 3.8%	16,907 $311,000
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $15,384 - $25,522	811 Added 5.24%	16,288 $426,000
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $282,455 - $355,971	15,477 New	15,477 $355,000

158

44.7M

64.8K

562K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $222M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.